Literature DB >> 23729393

Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib.

Koji Miyahara1, Kazuhiro Nouso, Yasuhiro Miyake, Shinichiro Nakamura, Shuntaro Obi, Maho Amano, Kazuko Hirose, Shin-Ichiro Nishimura, Kazuhide Yamamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23729393     DOI： 10.1002/hep.26531

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

1.  Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.

Authors:  Amr Amin; Asma Bashir; Nazar Zaki; Diane McCarthy; Sanjida Ahmed; Mohamed Lotfy
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

2.  Synthetic glycopeptides as a designated standard in focused glycoproteomics to discover serum cancer biomarkers.

Authors:  K V Yogesh; Toshiya Kamiyama; Chikara Ohyama; Tohru Yoneyama; Kazuhiro Nouso; Satoshi Kimura; Hiroshi Hinou; Shin-Ichiro Nishimura
Journal:  Medchemcomm       Date:  2018-06-29       Impact factor: 3.597

3.  Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.

Authors:  Daisuke Noro; Tohru Yoneyama; Shingo Hatakeyama; Yuki Tobisawa; Kazuyuki Mori; Yasuhiro Hashimoto; Takuya Koie; Masakazu Tanaka; Shin-Ichiro Nishimura; Hideo Sasaki; Mitsuru Saito; Hiroshi Harada; Tatsuya Chikaraishi; Hideki Ishida; Kazunari Tanabe; Shigeru Satoh; Chikara Ohyama
Journal:  Int J Mol Sci       Date:  2017-08-08       Impact factor: 5.923

Review 4.  Recent progress and perspectives on prostate cancer biomarkers.

Authors:  Shingo Hatakeyama; Tohru Yoneyama; Yuki Tobisawa; Chikara Ohyama
Journal:  Int J Clin Oncol       Date:  2016-10-11       Impact factor: 3.402

5.  Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.

Authors:  Takuma Narita; Shingo Hatakeyama; Tohru Yoneyama; Shintaro Narita; Shinichi Yamashita; Koji Mitsuzuka; Toshihiko Sakurai; Sadafumi Kawamura; Tatsuo Tochigi; Ippei Takahashi; Shigeyuki Nakaji; Yuki Tobisawa; Hayato Yamamoto; Takuya Koie; Norihiko Tsuchiya; Tomonori Habuchi; Yoichi Arai; Chikara Ohyama
Journal:  Cancer Med       Date:  2017-03-20       Impact factor: 4.452

6.  DNA hypomethylation upregulates expression of the MGAT3 gene in HepG2 cells and leads to changes in N-glycosylation of secreted glycoproteins.

Authors:  Marija Klasić; Jasminka Krištić; Petra Korać; Tomislav Horvat; Dora Markulin; Aleksandar Vojta; Karli R Reiding; Manfred Wuhrer; Gordan Lauc; Vlatka Zoldoš
Journal:  Sci Rep       Date:  2016-04-13       Impact factor: 4.379

7.  N6-methyladenosine (m6A) RNA methylation regulators are associated with clinical prognosis in hepatocellular carcinoma.

Authors:  Gao Li; Yue Zhang; Xiaowei Du; Wanjun Li; Yanming Zhang; Tao Han; Zhendong Zheng
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.